Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-024386
Filing Date
2024-10-02
Accepted
2024-10-02 16:16:12
Documents
2
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form3-10022024_081009.html 3  
1 form3-10022024_081009.xml 3 1687
2 ex24-10022024_081009.htm EX-24 5745
  Complete submission text file 0001415889-24-024386.txt   8921
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 101 CAMBRIDGE MA 02140
Business Address
Choi Han Wook (Reporting) CIK: 0002038629 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39979 | Film No.: 241347553